1. From 00:00 to 24:00 on March 29, a total of 1,629 new confirmed cases were reported in 31 provinces (autonomous regions and municipalities directly under the Central Government) and the Xinjiang Production and Construction Corps.Outside the input cases 64 cases (24 cases in sichuan, guangdong 13 cases, 9 cases in guangxi, yunnan, 4 cases, 3 cases of heilongjiang province, Shanghai 3 cases, 3 cases of fujian, shanxi in 2 cases, 1 case of Beijing, 1 case of Inner Mongolia, shandong 1 case), including 26 cases from asymptomatic infection to confirmed cases (20 cases in sichuan, guangdong (3 cases), 2 cases of heilongjiang province, shandong 1 case).There were 1,565 local cases (1,150 in Jilin, including 875 in Changchun, 268 in Jilin and 7 in Siping;In Shanghai, 326 cases were reported, including 169 in Pudong New Area, 34 in Xuhui District, 33 in Baoshan District, 29 in Minhang District, 15 in Songjiang District, 9 in Jiading District, 8 in Jing ‘an District, 7 in Hongkou District, 6 in Huangpu District, 6 in Putuo District, 3 in Yangpu District, 3 in Changning District, 2 in Jinshan District, 1 in Fengxian district and 1 in Chongming District.26 cases in Henan province, all in Zhoukou city;Sixteen cases were reported in Heilongjiang province, including 15 in Jiamusi and 1 in Harbin.Eight cases were reported in Zhejiang province, including 3 in Jiaxing, 3 in Huzhou, 1 in Hangzhou and 1 in Lishui.Seven cases were reported in Fujian, including 6 in Quanzhou city and 1 in Putian City.Six cases were reported in Hebei, including 3 in Qinhuangdao city and 3 in Langfang City.Five cases were reported in Liaoning province, including 3 in Shenyang, 1 in Yingkou and 1 in Huludao.Four cases were reported in Shandong province, including 1 in Qingdao, 1 in Zaozhuang, 1 in Tai ‘an and 1 in Dezhou.Three cases were reported in Anhui, including 2 in Huainan city and 1 in Wuhu City.3 cases were reported in Hunan province, including 2 in Changsha and 1 in Loudi.2 cases in Beijing, both in Tongzhou District;Two cases were reported in Tianjin, including one in Nankai District and one in Dongli District.Two cases were reported in Guangdong, including one in Shenzhen and one in Zhuhai.1 case in Jiangsu province, taizhou city;1 case in Jiangxi province, nanchang City;1 case in Hainan, wanning City;1 case in Chongqing, yunyang County;Among them, 24 were in Jilin, 18 in Shanghai, 13 in Heilongjiang, five in Fujian, two in Liaoning, two in Zhejiang, one in Tianjin and one in Hunan.No new deaths were reported.Two new suspected cases were reported, both imported (both in Shanghai).(source: National Health Commission) Today’s latest medical device information policy: ▶ The beijing-Tianjin-Hebei “3+N” alliance coronary artery expansion balloon collection results were released enterprise news: ▶ Xinwei Medical revenue in 2021 increased by 517% to 900.89 million yuan investment and financing: ▶ Yingsheng Biological completed hundreds of millions of yuan of ROUND C financing, in-depth layout of clinical mass spectrometry!Beijing, March 29 (Xinhua) — Tianjin Medical Procurement Center released the results of the “3+N” alliance of coronary artery dilation balloon medical consumables belt volume linkage selection.The variety purchased in this centralized and quantitative linkage was coronary dilatation balloon, with a structure of fast exchange type and functional properties including semi-compliant and non-compliant.Xinwei Medical 2021 revenue jumped 517% to 900.89 million Yuan on March 29, Xinwei medical released the results of the year ended December 31, 2021, the group achieved revenue of 900.89 million yuan, a year-on-year increase of 517%;Gross profit was 54.95 million yuan, up 675.36% year on year;The r&d cost was 76.306,000 yuan, up 49.23% year on year.(source:Oriental wealth network) English is filled with hundreds of millions of yuan C round of financing, the shandong sheng biotechnology co., LTD. Announced completion of hundreds of millions of yuan series C round of financing, Chen DE by existing shareholders, hillhouse capital venture jointly led, cicc Jin Qiyuan in the capital’s funds, taiping insurance group, taiping health funds, the far east hongxin’s alms with calendar, jing Ming capital with,Existing shareholders yuan sheng venture investment, three ze venture investment, Hui every capital continued to add.(source: CACLP In Vitro Diagnostics Information) one-stop procurement service platform, high value medical industry think tank.Heyihui Medical – make the business of medical equipment people easier!Editor: He Yi Hui Medical Statement: This article is edited to speed up the efficiency of information dissemination.If the source is wrong or violated your legitimate rights and interests, please contact the author with proof of ownership.For more information on bidding and equipment consumables procurement in the medical industry, please go to the public account and pay attention to “Heyihui Medical”.